Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide

被引：24
|
作者：
Trapella, Claudio [1 ,2 ]
Fischetti, Carmela [3 ,4 ,5 ]
Pela', Michela [1 ,2 ]
Lazzari, Ilaria [1 ,2 ]
Guerrini, Remo [1 ,2 ]
Calo', Girolamo [3 ,4 ]
Rizzi, Anna [3 ,4 ]
Camarda, Valeria [3 ,4 ]
Lambert, David G. [5 ]
McDonald, John [5 ]
Regoli, Domenico [3 ,4 ]
Salvadori, Severo [1 ,2 ]
机构：
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44100 Ferrara, Italy
[4] Univ Ferrara, Natl Inst Neurosci, I-44100 Ferrara, Italy
[5] Univ Leicester, Leicester Royal Infirm,Pharmacol & Therapeut Grp, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester LE1 5WW, Leics, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 14期
关键词：
SAR studies; NOP receptor antagonists; Receptor and [S-35]GTP gamma S binding; Mouse vas deferens; Calcium mobilization; Tail withdrawal assay; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO; AGONIST; POTENT; UFP-101; PROFILE; ORL1;
D O I：
10.1016/j.bmc.2009.05.068
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Twelve derivatives of the nociceptin/orphanin FQ (N/OFQ) receptor (NOP) antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide (Comp 24) were synthesised and tested in binding experiments performed on CHOhNOP cell membranes. Among them, a novel interesting NOP receptor antagonist (compound 35) was identified by blending chemical moieties taken from different NOP receptor ligands. In vitro in various assays, Compound 35 consistently behaved as a pure, highly potent (pA(2) in the range 8.0-9.9), competitive and NOP selective antagonist. However compound 35 was found inactive when challenged against N/OFQ in vivo in the mouse tail withdrawal assay. Thus the usefulness of the novel NOP ligand compound 35 is limited to in vitro investigations. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5080 / 5095
页数：16
相关论文
共 50 条
  • [1] 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices
    Liao, Yan-Yu
    Trapella, Claudio
    Chiou, Lih-Chu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 606 (1-3) : 84 - 89
  • [2] 3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists
    Russell, MGN
    Matassa, VG
    Pengilley, RR
    van Niel, MB
    Sohal, B
    Watt, AP
    Hitzel, L
    Beer, MS
    Stanton, JA
    Broughton, HB
    Castro, JL
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) : 4981 - 5001
  • [3] Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: Design, synthesis, and structure-activity relationships
    Hayashi, Shigeo
    Nakata, Eriko
    Morita, Asato
    Mizuno, Kunihiko
    Yamamura, Kenzo
    Kato, Aki
    Ohashi, Katsuyo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (21) : 7675 - 7699
  • [4] Synthesis and Antileukemic Activity of Novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl)piperidin-1-yl)ethanone Derivatives
    Vinaya, Kambappa
    Kavitha, Chandagirikoppal V.
    Prasanna, Doddakunche S.
    Chandrappa, Siddappa
    Ranganatha, Somasagara R.
    Raghavan, Sathees C.
    Rangappa, Kanchugarakoppal S.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (03) : 360 - 367
  • [5] Chiral NMR discrimination of the diastereoisomeric salts of the H3-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole
    Rivara, Mirko
    Zuliani, Valentina
    Fantini, Marco
    Dallaturca, Elisa
    Mor, Marco
    MAGNETIC RESONANCE IN CHEMISTRY, 2009, 47 (06) : 515 - 518
  • [6] Pharmacological properties of a novel nociceptin/orphanin FQ receptor agonist, 2-(3,5-dimethylpiperazin-1-yl)-1-[1-(1-methylcyclooctyl) piperidin-4-yl]-1H-benzimidazole, with anxiolytic potential
    Hirao, Akiko
    Imai, Aki
    Sugle, Yutaka
    Tamura, Tetsuya
    Shimokawa, Hirohisa
    Tolde, Katsuo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) : 189 - 195
  • [7] 3-[2-(pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: Agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype
    Castro, JL
    Street, LJ
    Guiblin, AR
    Jelley, RA
    Russell, MGN
    Sternfeld, F
    Beer, MS
    Stanton, JA
    Matassa, VG
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) : 3497 - 3500
  • [8] Molecular interaction of the antagonist N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor
    Shim, JY
    Welsh, WJ
    Cartier, E
    Edwards, JL
    Howlett, AC
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (07) : 1447 - 1459
  • [9] Piperazine-Derived α1D/1A Antagonist 1-Benzyl-N- (3-(4-(2-Methoxyphenyl) Piperazine-1-yl) Propyl)-1H-Indole-2-Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking
    Xiao, Qing
    Liu, Qi-Meng
    Jiang, Ru-Chao
    Chen, Kai-Feng
    Zhu, Xiang
    Ma, Lei
    Li, Wei-Xi
    He, Fei
    Huang, Jun-Jun
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [10] Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist
    Guerrini, R
    Calo', G
    Bigoni, R
    Rizzi, D
    Regoli, D
    Salvadori, S
    JOURNAL OF PEPTIDE RESEARCH, 2001, 57 (03): : 215 - 222
12345